- Home
- CNTA vs PAX Comparison
CNTA vs PAX Comparison
Compare CNTA & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- PAX
- Stock Information
- Founded
- CNTA 2020
- PAX 1988
- Country
- CNTA United Kingdom
- PAX Cayman Islands
- Employees
- CNTA N/A
- PAX N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- PAX Investment Managers
- Sector
- CNTA Health Care
- PAX Finance
- Exchange
- CNTA Nasdaq
- PAX Nasdaq
- Market Cap
- CNTA 2.2B
- PAX 1.8B
- IPO Year
- CNTA 2021
- PAX 2021
- Fundamental
- Price
- CNTA $14.59
- PAX $11.39
- Analyst Decision
- CNTA Strong Buy
- PAX Strong Buy
- Analyst Count
- CNTA 8
- PAX 1
- Target Price
- CNTA $23.86
- PAX $14.00
- AVG Volume (30 Days)
- CNTA 1.1M
- PAX 546.3K
- Earning Date
- CNTA 03-24-2025
- PAX 05-01-2025
- Dividend Yield
- CNTA N/A
- PAX 5.26%
- EPS Growth
- CNTA N/A
- PAX N/A
- EPS
- CNTA N/A
- PAX 0.48
- Revenue
- CNTA N/A
- PAX $374,200,000.00
- Revenue This Year
- CNTA N/A
- PAX $6.32
- Revenue Next Year
- CNTA N/A
- PAX $3.91
- P/E Ratio
- CNTA N/A
- PAX $24.25
- Revenue Growth
- CNTA N/A
- PAX 14.22
- 52 Week Low
- CNTA $7.75
- PAX $10.50
- 52 Week High
- CNTA $19.09
- PAX $14.90
- Technical
- Relative Strength Index (RSI)
- CNTA 38.85
- PAX 45.60
- Support Level
- CNTA $13.78
- PAX $11.62
- Resistance Level
- CNTA $16.87
- PAX $11.98
- Average True Range (ATR)
- CNTA 1.07
- PAX 0.28
- MACD
- CNTA -0.23
- PAX 0.03
- Stochastic Oscillator
- CNTA 19.33
- PAX 48.72
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
About PAX Patria Investments Limited
Patria Investments Ltd is a private markets investment firm. It seeks to provide global and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns.